Literature DB >> 12591170

Progesterone in gestational diabetes mellitus: guilty or not guilty?

Dumitru D Brănişteanu1, Chantal Mathieu.   

Abstract

Insulin resistance is one of the metabolic changes in pregnancy, but only a fraction of women develop overt impaired glucose tolerance or frank diabetes. Most women are able to compensate this altered metabolic state by increasing the amount of insulin produced by the pancreatic beta cells. Progesterone might well be the key to the development of gestational diabetes. Previously high progesterone levels have already been shown to be correlated with the development of glucose abnormalities in pregnancy and now, in a new paper, progesterone receptor-knockout mice are found to have improved glucose tolerance. These mice showed increased insulin secretion, which is probably linked to the presence of increased numbers of beta cells in their pancreas. Is progesterone therefore the 'ultimate bad guy', prohibiting normal adaptation of the pancreatic beta-cell reserve during pregnancy?

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12591170     DOI: 10.1016/s1043-2760(03)00003-1

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  23 in total

1.  Pregnancy and Smoothelin-like Protein 1 (SMTNL1) Deletion Promote the Switching of Skeletal Muscle to a Glycolytic Phenotype in Human and Mice.

Authors:  Beata Lontay; Khaldon Bodoor; Adrienn Sipos; Douglas H Weitzel; David Loiselle; Rachid Safi; Donghai Zheng; James Devente; Robert C Hickner; Donald P McDonnell; Thomas Ribar; Timothy A Haystead
Journal:  J Biol Chem       Date:  2015-06-05       Impact factor: 5.157

2.  Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement.

Authors:  Sherita Hill Golden; Arleen Brown; Jane A Cauley; Marshall H Chin; Tiffany L Gary-Webb; Catherine Kim; Julie Ann Sosa; Anne E Sumner; Blair Anton
Journal:  J Clin Endocrinol Metab       Date:  2012-06-22       Impact factor: 5.958

Review 3.  Exploring the causes and consequences of maternal metabolic maladaptations during pregnancy: Lessons from animal models.

Authors:  Amanda N Sferruzzi-Perri; Jorge Lopez-Tello; Tina Napso; Hannah E J Yong
Journal:  Placenta       Date:  2020-01-31       Impact factor: 3.481

4.  Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Authors:  John V Ilekis; Ekaterini Tsilou; Susan Fisher; Vikki M Abrahams; Michael J Soares; James C Cross; Stacy Zamudio; Nicholas P Illsley; Leslie Myatt; Christine Colvis; Maged M Costantine; David M Haas; Yoel Sadovsky; Carl Weiner; Erik Rytting; Gene Bidwell
Journal:  Am J Obstet Gynecol       Date:  2016-03-10       Impact factor: 8.661

5.  The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies.

Authors:  Cynthia Gyamfi; Amanda L Horton; Valerija Momirova; Dwight J Rouse; Steve N Caritis; Alan M Peaceman; Anthony Sciscione; Paul J Meis; Catherine Y Spong; Mitchell Dombrowski; Baha Sibai; Michael W Varner; Jay D Iams; Brian M Mercer; Marshall W Carpenter; Julie Lo; Susan M Ramin; Mary Jo O'Sullivan; Menachem Miodovnik; Deborah Conway
Journal:  Am J Obstet Gynecol       Date:  2009-08-29       Impact factor: 8.661

6.  The interplay of prolactin and the glucocorticoids in the regulation of beta-cell gene expression, fatty acid oxidation, and glucose-stimulated insulin secretion: implications for carbohydrate metabolism in pregnancy.

Authors:  Ramamani Arumugam; Eric Horowitz; Danhong Lu; J Jason Collier; Sarah Ronnebaum; Don Fleenor; Michael Freemark
Journal:  Endocrinology       Date:  2008-07-03       Impact factor: 4.736

Review 7.  The role of oestrogens in the adaptation of islets to insulin resistance.

Authors:  Angel Nadal; Paloma Alonso-Magdalena; Sergi Soriano; Ana B Ropero; Ivan Quesada
Journal:  J Physiol       Date:  2009-08-17       Impact factor: 5.182

8.  Genetic variants in sex hormone pathways and the risk of type 2 diabetes among African American, Hispanic American, and European American postmenopausal women in the US.

Authors:  Atsushi Goto; Brian H Chen; Kei-Hang K Chan; Cathy Lee; Sarah C Nelson; Andrew Crenshaw; Ebony Bookman; Karen L Margolis; Michèle M Sale; Maggie C Y Ng; Alexander P Reiner; Simin Liu
Journal:  J Diabetes       Date:  2018-04-06       Impact factor: 4.006

Review 9.  Sex-related differences in diabetic kidney disease: A review on the mechanisms and potential therapeutic implications.

Authors:  Federica Piani; Isabella Melena; Kalie L Tommerdahl; Natalie Nokoff; Robert G Nelson; Meda E Pavkov; Daniël H van Raalte; David Z Cherney; Richard J Johnson; Kristen J Nadeau; Petter Bjornstad
Journal:  J Diabetes Complications       Date:  2020-12-31       Impact factor: 2.852

10.  Gestational diabetes mellitus resulting from impaired beta-cell compensation in the absence of FoxM1, a novel downstream effector of placental lactogen.

Authors:  Hongjie Zhang; Jia Zhang; Christine F Pope; Laura A Crawford; Rupangi C Vasavada; Shubhada M Jagasia; Maureen Gannon
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.